RxDoctor Payments Data

Asad Al Aboud, MD

Internal Medicine · Nashville, TNNPI 1760725915

Payments from drug & device makers

What this record shows

This record is dominated by grants: $37,500 of the $44,314 with a category attached, or 84.6%. Medtronic accounts for 89.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $25,000 and has fallen 99.1% since, to $216 in 2025. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,314in general payments, 2019–2025

Across 76 payments — averaging $583.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$39K
  • Philips North America LLC$2K
  • Biotronik Inc.$2K
  • Biosense Webster, Inc.$220
  • Boston Scientific$198
  • Heartflow, Inc.$124
  • plus $238 from 7 others

What the payments were for

  • Grants$37,50085%
  • Travel & lodging$3,4388%
  • Food & beverage$3,3758%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,314 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$424,303
Medicare patients
827
Services billed
4,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban409$403,123
XareltoRivaroxaban136$139,602
Dofetilide70$12,389
MultaqDronedarone Hcl13$11,555
Flecainide Acetate287$9,184
Dabigatran EtexilateDabigatran Etexilate Mesylate31$5,564
Amiodarone Hcl141$5,163
Metoprolol Succinate246$3,963
Droxidopa12$2,909
Midodrine Hcl18$2,416
Mexiletine Hcl18$1,813
SotalolSotalol Hcl82$1,562
Propafenone Hcl ErPropafenone Hcl12$1,479
Diltiazem 24hr Er (Cd)Diltiazem Hcl53$1,412
ClopidogrelClopidogrel Bisulfate51$529

Paid to pharmacies, not to this prescriber.

Other internal medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →